Italia markets closed

TEVA Jul 2024 17.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0800-0,0100 (-11,11%)
In data: 12:14PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0900
Aperto0,0800
Denaro0,0300
Domanda0,1200
Prezzo d'esercizio17,50
Scadenza2024-07-12
Min-Max giorno0,0800 - 0,0800
Contratto - Min-MaxN/D
Volume3
Open Interest134
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.